GOLD stage 1 is crying wolf

Thorax

Volumn 64, Issue 2, 2009, Pages 182-183

  Enright, P L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT;

ADULT; ASTHMA; BRONCHITIS; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; COUGHING; DYSPNEA; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HUMAN; LETTER; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; RESPIRATORY CARE; SMOKING; SPIROMETRY; VIRAL RESPIRATORY TRACT INFECTION; NOTE; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; VITAL CAPACITY;

ADULT; FORCED EXPIRATORY VOLUME; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTORS; VITAL CAPACITY;

EID: 60549103273     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Bridevaux PO, Gerbase MW, Probst-Hensch NM, et al. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax 2008;63:768-74.
2. Pellegrino R, Brusasco V, Viegi G, et al. Definition of COPD: based on evidence or opinion? Eur Respir J 2008;31:681-2.
3. Pérez-Padilla R, Hallal PC, Vázquez-García JC, et al for the PLATINO group. Impact of bronchodilator use on the prevalence of COPD in population-based samples. COPD 2007;4:113- 20.
4. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002;166:675-9.
5. Qaseem A, Snow V, Shekelle P, et al for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Diagnosis and management of stable COPD: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2007;147:633-8.